MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 6, 2006; DOI: 10.1124/mol.105.019109


0026-895X/06/6904-1137-1145$20.00
Mol Pharmacol 69:1137-1145, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019109v1
69/4/1137    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, J.
Right arrow Articles by Pan, Z. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, J.
Right arrow Articles by Pan, Z. Z.
Original Article

Emergence of Functional {delta}-Opioid Receptors Induced by Long-Term Treatment with Morphine

Junyi Ma, Yong Zhang, Alex E. Kalyuzhny, and Zhizhong Z. Pan

Department of Anesthesiology and Pain Medicine, the University of Texas-MD Anderson Cancer Center, Houston, Texas (J.M., Y.Z., Z.Z.P.); and Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota (A.E.K.)

Abstract

Opioid analgesics remain the choice for the treatment of moderate to severe pain. Recent research has established that the µ-opioid receptor is predominantly responsible for mediating many opioid actions, including analgesia and opioid tolerance. However, the function of {delta}-opioid receptors is rather puzzling at present, with inconsistent reports of system effects by agonists of {delta}-opioid receptors. The functional interaction between µ-opioid receptors and {delta}-opioid receptors is also poorly understood. In this study, we demonstrated that in a brainstem site critically involved in opioid analgesia, agonists of {delta}-opioid receptors, ineffective in opioid naive rats, significantly inhibit presynaptic GABA release in the brainstem neurons from morphine-tolerant rats. In membrane preparation from control brainstem tissues, Western blot detected no proteins of {delta}-opioid receptors, but consistent {delta}-opioid receptor proteins were expressed in membrane preparation from morphine-tolerant rats. Immunohistochemical studies revealed that long-term morphine treatment significantly increases the number of {delta}-opioid receptor-immunoreactive varicosities that appose the postsynaptic membrane of these neurons. The colocalization of {delta}-opioid receptor-immunoreactive varicosities with the labeling of the GABA-synthesizing enzyme glutamic acid decarboxylase is also significantly increased. From a behavioral perspective, activation of {delta}-opioid receptors in the brainstem nucleus, lacking an effect in opioid naive rats, became analgesic in morphine-tolerant rats and significantly reduced morphine tolerance. These findings indicate that long-term morphine treatment induces the emergence of functional {delta}-opioid receptors and {delta}-opioid receptor-mediated analgesia, probably through receptor translocation to surface membrane in GABAergic terminals. They also suggest that opioid drugs with preference for {delta}-opioid receptors may have better therapeutic effect in a µ-opioid-tolerant state.


Received September 17, 2005; accepted January 6, 2006

Address correspondence to: Dr. Zhizhong Z. Pan, Department of Anesthesiology and Pain Medicine, Unit 110, University of Texas-MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. E-mail: zzpan{at}mdanderson.org




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond
Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 813 - 821.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics